Rockefeller University Library is Officially Open!

Posted on by

It is with pleasure that we share that the Markus Library has reopened its doors as their renovation project has come to an end!  The TRI-I Community, which includes MSK staff, is welcome back to the Library in Welch Hall, Monday to Friday, between 9:00 am and 5:00 pm. The double doors to the main reading room and door to the B level study/book collection room are controlled by ID badge readers, but they will be off during business hours.  The library is now located on the second and third floors of Welch Hall.

MSK staff will have access to the book collections, computers, and study spaces.   Should you require any research support or if you would like a mediated-search conducted on your behalf, please continue to Ask-Us!

Resource Highlights: Chemotherapy Advisor

Posted on by

A resource for oncology healthcare professionals, Chemotherapy Advisor, offers information by cancer type, news updates, and multimedia content to provide engaging and up-to-date information to its users. Their mission: to empower oncology healthcare professionals with practice-focused and comprehensive clinical and drug information that is reflective of current and emerging principles of care to optimize patient outcomes.

Continue reading →

MSKCC in the News: April 3 – April 24

Posted on by
  • MSKCC is profiled in a New York Times article about major academic medical centers in New York and around the country that are spending and recruiting heavily on genomic sequencing programs.
  • Researchers from Cornell and MSKCC have published results of a study that revealed that spongelike nanoparticles whose pores can be filled with drugs may offer the promise of drug delivery to specific targets in the body.
  • Genetically engineered immune cells can drive an aggressive type of leukemia into retreat, an MSKCC clinical trial suggests.
  • Charles Sawyers of MSKCC is quoted in a Nature article advocating for cancer researchers to focus on single-subject, or ‘n-of-1’, studies that could offer new insights into cancer.
  • A new study published in the British Medical Journal from researchers at MSKCC suggest that aside from men with a history of prostate cancer, other groups at high risk for the disease may be identified with a single PSA test when they are in their 40s.